Skip to main content

Table 1 Non-representative country averages for countries with >20 responses

From: Impact of availability of guidelines and active surveillance in reducing the incidence of ventilator-associated pneumonia in Europe and worldwide

Country Number of responses Number of pseudo-ICUs Mean years of experience in critical care Proportion female sex Number of beds in ICU Availability of VAP prevention standards Existence of VAP surveillance system VAP measure 1 VAP measure 2 VAP measure 3 VAP measure 4 VAP measure 5 VAP measure 6 Sum of VAP measures 1-6
AR 40 24 15.00 25% 13.20 65% 68% 100% 63% 73% 98% 78% 78% 4.88
AT 130 58 12.75 35% 8.97 40% 45% 96% 44% 47% 93% 98% 82% 4.59
AU 23 17 14.17 9% 19.43 30% 30% 100% 48% 39% 70% 100% 91% 4.48
BE 33 25 17.21 24% 21.15 73% 48% 100% 52% 91% 55% 97% 94% 4.88
BR 21 18 13.86 10% 20.71 81% 76% 100% 71% 86% 95% 62% 67% 4.81
CH 29 16 9.90 24% 12.93 69% 38% 97% 69% 72% 86% 86% 93% 5.03
CO 31 19 9.45 29% 14.84 68% 74% 97% 55% 84% 87% 77% 97% 4.97
DE 67 49 11.81 15% 22.93 67% 52% 97% 54% 60% 93% 99% 84% 4.85
ES 293 107 16.10 38% 15.80 81% 74% 98% 43% 94% 93% 93% 87% 5.09
FR 251 113 11.50 24% 14.88 47% 61% 96% 19% 55% 69% 90% 94% 4.24
GB 115 57 10.74 22% 17.16 79% 50% 98% 81% 90% 50% 87% 87% 4.92
GR 23 15 11.35 61% 11.00 30% 39% 96% 30% 83% 61% 52% 74% 3.96
IN 63 44 9.25 6% 23.94 81% 79% 100% 95% 90% 84% 81% 97% 5.48
IT 187 56 15.47 34% 8.34 60% 48% 91% 35% 76% 50% 70% 70% 3.93
MX 31 19 10.97 10% 10.16 52% 68% 97% 42% 39% 87% 90% 81% 4.35
NL 31 22 9.06 16% 20.87 81% 39% 81% 61% 35% 68% 84% 87% 4.16
PE 23 15 14.52 9% 12.96 43% 57% 96% 48% 4% 91% 78% 48% 3.65
PT 50 27 12.46 42% 12.18 58% 68% 100% 38% 80% 68% 78% 84% 4.48
  1. Availability of VAP prevention standards: country averages of positive responses to the question (yes/no): “In my ICU, we have written clinical guidelines for the prevention of ventilator-associated pneumonia”.
  2. Existence of VAP surveillance system: country averages of positive responses to the question (yes/no): “in my ICU, we count and record VAP on a routine basis”.
  3. VAP prevention measure 1: Head of bed elevation; VAP prevention measure 2: daily sedation and weaning protocol; VAP prevention measure 3: Oral care with chlorhexidine; VAP prevention measure 4: No ventilator circuit change unless indicated; VAP prevention measure 5: Cuff pressure control at lease every 24 hrs; VAP prevention measure 6: Strict hand hygiene using alcohol.
  4. Only countries with >20 responses are included in Table 1.
  5. Country appreviations: ES = SPAIN; FR = FRANCE; IT = ITALY; AT = AUSTRIA; GB = UNITED KINGDOM; DE = GERMANY; IN = INDIA; PT = PORTUGAL; AR = ARGENTINA; BE = BELGIUM; CO = COLOMBIA; MX = MEXICO; NL = NETHERLANDS; CH = SWITZERLAND; AU = AUSTRALIA; GR = GREECE; PE = PERU; BR = BRAZIL.